Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01310
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Myeloid-Derived Suppressor Cells as Effectors of Immune Suppression in Cancer

International Journal of Cancer
Cancer ResearchOncology
2016English

Myeloid-Derived Suppressor Cells and Myeloid Regulatory Cells in Cancer and Autoimmune Disorders

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2016English

HMGB1 Promotes Myeloid-Derived Suppressor Cells and Renal Cell Carcinoma Immune Escape

Oncotarget
Oncology
2017English

Tumor-Derived Lactate and Myeloid-Derived Suppressor Cells: Linking Metabolism to Cancer Immunology

OncoImmunology
OncologyAllergyImmunology
2013English

Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications

Seminars in Oncology
OncologyHematology
2014English

Myeloid Derived Suppressor Cells: Subsets, Expansion, and Role in Cancer Progression

2012English

Myeloid-Derived Suppressor Cells in Autoimmune Diseases

Inflammation and Regeneration
AllergyImmunology
2014English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy